NCT06824896View on ClinicalTrials.gov

A Post-marketing Observational Database Study Monitoring the Safety of CecolinⓇ

CompletedOBSERVATIONAL
Enrollment

1,322,084

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Autoimmune DiseasesAdverse Pregnancy Outcomes
Trial Locations (1)

361022

Xiamen Innovax Biotech Co., Ltd, Xiamen

All Listed Sponsors
collaborator

Xiamen University

OTHER

collaborator

Xiamen Health and Medical Big Data Center

UNKNOWN

lead

Xiamen Innovax Biotech Co., Ltd

INDUSTRY

NCT06824896 - A Post-marketing Observational Database Study Monitoring the Safety of CecolinⓇ | Biotech Hunter | Biotech Hunter